Alibaba Group vs Zoetis Inc — how do they compare? Alibaba Group trades at $125.35 (market cap $308.93B), while Zoetis Inc trades at $73.7 (market cap $31.14B). The key difference: Alibaba Group is far larger — about 9.9× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.81%). Which is the better fit depends on your goals.
| BABA | ZTS | |
|---|---|---|
Market Cap | $308.93B | $31.14B |
Volume | 18,069,938 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $189.34 | $156.76 |
52-Week Low | $94.83 | $71.91 |
Enterprise Value | $303.72B | $38.70B |
Dividend Yield | 0.82% | 2.81% |
Signals from Pluang's Aura AI — not financial advice
Alibaba (BABA) trades at $124.80, down 5.69% on the day amid ongoing legal pressures and earnings misses. The stock shows bullish technical signals with strong moving average support but faces fundamental headwinds from three consecutive quarterly EPS misses. Revenue growth remains positive at $996.35 billion for 2025, with improved net income margin of 13.05%, though cash flow turned negative at -$97.16 billion due to heavy investing activity.
Despite analyst optimism with 86% buy ratings and $195 consensus target, significant legal risks from multiple class action lawsuits and recent earnings underperformance create near-term uncertainty. The 56% upside to target suggests potential value if legal and operational challenges resolve, but investors face elevated regulatory and execution risks in the Chinese market environment.
Zoetis (ZTS) trades at $73.4, down 1.95% on the day, as technical indicators signal a bearish trend amid recent price weakness. Fundamentally, the company reported Q2 2026 EPS of $1.87, beating estimates, but revenue was flat and full-year guidance was cut due to softer pet healthcare demand. Analyst sentiment remains mixed with a consensus price target of $94.90, though recent news highlights competitive pressures and a securities class action lawsuit.
The stock presents a value opportunity given its attractive P/E of 12.29 and strong profitability margins, but near-term headwinds from U.S. companion-animal market challenges and legal overhangs pose risks. Upside depends on execution against revised 2026 targets and stabilization in core markets.
Trailing returns across standard periods
Alibaba Group Holding Limited operates as a holding company. The Company provides internet infrastructure, electronic commerce, online financial, and internet content services through its subsidiaries. Alibaba Group Holding offers its products and services worldwide.
Read more on BABA →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →